A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)

Peer Review reports

Original Submission
20 Nov 2018	Submitted	Original manuscript
29 Apr 2019	Reviewed	Reviewer Report - Huiyun Zhu
15 May 2019	Reviewed	Reviewer Report - Kai Zheng
20 May 2019	Reviewed	Reviewer Report - Abhai Verma
11 Jul 2019	Author responded	Author comments - Mitchell Ramsey
Resubmission - Version 2
11 Jul 2019	Submitted	Manuscript version 2
15 Jul 2019	Reviewed	Reviewer Report - Abhai Verma
18 Jul 2019	Reviewed	Reviewer Report - Kai Zheng
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
20 Jul 2019	Editorially accepted
14 Aug 2019	Article published	10.1186/s13063-019-3606-y

Back to article page